Filter
2582
Filtered Results: 2582
Text search:
drug
trial
Featured
Recommendations
238
New Publications
496
Language
Document type
No document type
1484
Studies & Reports
415
Guidelines
409
Manuals
114
Strategic & Response Plan
58
Fact sheets
43
Training Material
26
Situation Updates
11
Infographics
9
Resource Platforms
6
Brochures
5
App
1
Videos
1
Countries / Regions
India
144
Global
97
South Africa
66
Western and Central Europe
55
Kenya
45
Nigeria
41
Ethiopia
37
Uganda
35
Africa
33
Tanzania
30
Eastern Europe
29
Zambia
29
Liberia
29
Malawi
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
24
Latin America and the Carribbean
23
Zimbabwe
20
Rwanda
19
Asia
19
Bangladesh
18
Philippines
17
Myanmar / Burma
16
South–East Asia Region
15
Namibia
15
Brazil
14
Mozambique
12
East and Southern Africa
12
Colombia
11
Lesotho
11
Cambodia
10
Germany
10
West and Central Africa
10
South Sudan
9
Indonesia
9
USA
8
Middle East and North Africa
8
Thailand
7
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Syria
6
Cameroon
5
Albania
5
Senegal
5
Guinea
5
Eastern Europe and Central Asia
5
Vietnam
5
Laos
4
Burkina Faso
4
Argentina
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Venezuela
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
France
2
United Kingdom
2
Portugal
2
Belarus
2
Bolivia
2
Sri Lanka
2
Poland
2
Mali
2
Iraq
2
Timor Leste/ East Timor
1
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
Tunisia
1
Norway
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Chad
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
700
Clinical Guidelines
323
Public Health
129
Women & Child Health
99
Key Resources
36
Pharmacy & Technologies
30
Capacity Building
18
Toolboxes
HIV
349
Mental Health
340
TB
302
COVID-19
162
NTDs
149
AMR
89
NCDs
77
Pharmacy
71
Ebola & Marburg
58
Malaria
57
Rapid Response
35
Caregiver
32
Refugee
28
Disability
24
Planetary Health
23
Health Financing Toolbox
17
Global Health Education
15
Conflict
14
Polio
10
Social Ethics
7
Cholera
6
Specific Hazards
5
Natural Hazards
5
Zika
4
Accessed Febr.6, 2020
This companion document to Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030 ("the road map") aims to support a range of stakeholders - including countries in which neglected tropical diseases (NTDs) are endemic, international organi...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
In recent decades, India has witnessed a rapidly exploding epidemic of diabetes.
Indeed, India today has the second largest number of people with diabetes in the
world. The International Diabetes Federation (IDF) estimates that there are 72.9 million people with diabetes in India in 2017, which is...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...
Global Happiness Council
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic assessment instrument developed by WHO to provide a standardized method for measuring health and disability across cultures. It was developed from a comprehensive set of International Classification of Functioning...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
This document has been developed for the WHO Regional Office for the Eastern Mediterranean to establish a regional plan of action to support the countries of the Region to rapidly accelerate the scaling up of their capacities for the prevention and early detection of, and ...
To evaluate the epidemiological evolution of patients with HIV (PtHIV), between 2002 and 2012, in a day-hospital that became an HIV reference centre for south-west Burkina Faso.
This was a retrospective study of PtHIV followed in the Bobo Dioulasso university hospital since 2002. The study was ba...
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.
The new Global AIDS Strategy 2021--2026, End Inequalities, End AIDS, is a bold approach that uses an inequalities lens to close the gaps preventing progress to end AIDS
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent disruption to health system functioning, reconstruction of the health system is integral to the country...
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
